Company: BDRX
Filing Date: 2025-11-17
Form Type: POS AM
Source: 0001214659-25-016809
Chunk: 25

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-11-17
Form: POS AM
Chunk 25
---
 beneficial ownership limitation of 9.99%, which does not permit the selling      
 shareholder to exercise that portion of the warrants that would result in the selling shareholder 
 and its affiliates owning, after exercise, a number of our Ordinary Shares in excess of the       
 beneficial ownership limitation. The amounts and percentages in the table do not give effect      
 to the 9.99% beneficial ownership limitation, if applicable. The principal business address       
 of Walleye Opportunities Master Fund Ltd is 2800 Niagara Lane North, Plymouth, MN 55447.          |

| 16 |

<div align='center'>DESCRIPTION OF OFFERED SECURITIES AND OUR SHARE CAPITAL</div>

The following describes our issued share capital, summarizes the material provisions of our Articles of Association and highlights certain differences in corporate law in the United Kingdom and the United States. This description of our share capital and summary of our Articles of Association is not complete, and is qualified by reference to our Articles of Association. You should read our Articles of Association, which are filed as an exhibit to the registration statement of which this prospectus forms a part, for the provisions that are important to you.

General

We are a public limited company organized
under the laws of England and Wales under registered number 09216368. Our registered office is 1 Caspian Point, Caspian Way, Cardiff,
CF10 4DQ, United Kingdom. The principal legislation under which we operate and our shares are issued is the Companies Act.

Our issued share capital
as of June 30, 2025 and November 1, 2025 was 61,952,308,922 Ordinary Shares, with each Ordinary Share having a nominal value of £0.000001
per share. Each issued Ordinary Share is fully paid. We currently have 1,000,001 A deferred shares, 4,063,321,418 B deferred shares,
126,547,389,518 C deferred shares, and 2,482,747,137,178 D deferred shares.

There is no limit to the number of
Ordinary Shares that we are authorized to issue, as the concept of authorized capital is no longer applicable under the provisions of
the Companies Act. There are no conversion rights, redemption provisions or sinking fund provisions relating to anyOrdinary Shares.

We are not permitted under English
law to hold our own Ordinary Shares unless they are repurchased by us and held in treasury. We do not currently hold any of our own Ordinary
Shares.

History of Share